Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells

Photodermatology Photoimmunology and Photomedicine

Volumn 27, Issue 2, 2011, Pages 97-107

  Akilov, Oleg E ^a,b   Wu, Mei X ^a   Jin, Yongzhu ^a   Zhou, Zhuoyan ^a   Geskin, Larisa J ^b   Falo, Louis D ^b   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Leishmania; Macrophage; T regulatory cells; Tolerance; Vaccination

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHATE BUFFERED SALINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FREEZE THAWING; LEISHMANIA MAJOR; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFER; MACROPHAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PARASITE LOAD; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROMASTIGOTE; REGULATORY T LYMPHOCYTE; TISSUE INJURY; VACCINATION;

ANIMALS; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; T-LYMPHOCYTES, REGULATORY;

EID: 79952505110     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2011.00578.x     Document Type: Article

References (43)

1. Viorritto IC, Nikolov NP, Siegel RM. Autoimmunity versus tolerance: can dying cells tip the balance? Clin Immunol 2007; 122: 125-134.
2. Lam M, Oleinick NL, Nieminen AL. Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. Reactive oxygen species and mitochondrial inner membrane permeabilization. J Biol Chem 2001; 276: 47379-47386.
3. Ball DJ, Luo Y, Kessel D, Griffiths J, Brown SB, Vernon DI. The induction of apoptosis by a positively charged methylene blue derivative. J Photochem Photobiol B 1998; 42: 159-163.
4. Noodt BB, Rodal GH, Wainwright M, et al. Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer 1998; 75: 941-948.
5. Kayes SG. Nonspecific allergic granulomatosis in the lungs of mice infected with large but not small inocula of the canine ascarid, Toxocara canis. Clin Immunol Immunopathol 1986; 41: 55-65.
6. Zaccone P, Fehervari Z, Phillips JM, Dunne DW, Cooke A. Parasitic worms and inflammatory diseases. Parasite Immunol 2006; 28: 515-523.
7. Andrade ZA, Reed SG, Roters SB, Sadigursky M. Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol 1984; 114: 137-148.
8. Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J Immunol 2002; 168: 5589-5595.
9. Godkin A, Ng WF, Gallagher K, Betts G, Thomas HC, Lechler RI. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage? J Allergy Clin Immunol 2008; 121: 1277-1284, e1273.
10. Guilliams M, Bosschaerts T, Herin M, et al. Experimental expansion of the regulatory T cell population increases resistance to African trypanosomiasis. J Infect Dis 2008; 198: 781-791.
11. Vojdani A, Erde J. Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III). Evid Based Complement Alternat Med 2006; 3: 309-316.
12. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
13. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 2000; 165: 969-977.
14. Spath GF, Beverley SM. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 2001; 99: 97-103.
15. Flamant S, Lebastard M, Pescher P, Besmond C, Milon G, Marchal G. Enhanced cloning efficiency of mouse bone marrow macrophage progenitors correlates with increased content of CSF-1 receptor of their progeny at low oxygen tension. Microbes Infect 2003; 5: 1064-1069.
16. Belkaid Y, Kamhawi S, Modi G, et al. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 1998; 188: 1941-1953.
17. Erickson-Miller CL, May RD, Tomaszewski J, et al. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chemother Pharmacol 1997; 39: 467-472.
18. Schaeppi U, Fleischman RW, Cooney DA. Toxicity of camptothecin (NSC-100880). Cancer Chemother Rep 1974; 5: 25-36.
19. Iellem A, Mariani M, Lang R, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194: 847-853.
20. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The majority of human peripheral blood CD4+CD25 high Foxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 2006; 177: 4488-4494.
21. Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA, Tacchini-Cottier F. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+T cells. J Immunol 2002; 169: 3232-3241.
22. Stassen M, Jonuleit H, Muller C, et al. Differential regulatory capacity of CD25+T regulatory cells and preactivated CD25+T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 2004; 173: 267-274.
23. Louis JA, Gumy A, Voigt H, Launois P, Rocken M. The use of the murine model of infection with Leishmania major to reveal the antagonistic effects that IL-4 can exert on T helper cell development and demonstrate that these opposite effects depend upon the nature of the cells targeted for IL-4 signaling. Pathol Biol (Paris) 2003; 51: 71-73.
24. Locksley RM, Louis JA. Immunology of leishmaniasis. Curr Opin Immunol 1992; 4: 413-418.
25. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 2: 845-858.
26. Vouldoukis I, Becherel PA, Riveros-Moreno V, et al. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 1997; 27: 860-865.
27. Raupach B, Kaufmann SH. Immune responses to intracellular bacteria. Curr Opin Immunol 2001; 13: 417-428.
28. Trinchieri G, Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res Immunol 1995; 146: 423-431.
29. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-4027.
30. Assreuy J, Cunha FQ, Epperlein M, et al. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol 1994; 24: 672-676.
31. Montagnoli C, Fallarino F, Gaziano R, et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 2006; 176: 1712-1723.
32. Gregg RK, Jain R, Schoenleber SJ, et al. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J Immunol 2004; 173: 7308-7316.
33. Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 2007; 178: 7849-7858.
34. Kochetkova I, Trunkle T, Callis G, Pascual DW. Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J Immunol 2008; 181: 2741-2752.
35. Jaffar Z, Ferrini ME, Girtsman TA, Roberts K. Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 2009; 39: 3307-3314.
36. Baba N, Rubio M, Sarfati M. Interplay between CD45RA+ regulatory T cells and TNF-alpha in the regulation of human Th17 differentiation. Int Immunol 2010; 22: 237-244.
37. Brustle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007; 8: 958-966.
38. Ahyi AN, Chang HC, Dent AL, Nutt SL, Kaplan MH. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J Immunol 2009; 183: 1598-1606.
39. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+CD25+T cells regulate virus-specific primary and memory CD8+T cell responses. J Exp Med 2003; 198: 889-901.
40. Kursar M, Bonhagen K, Fensterle J, et al. Regulatory CD4+CD25+T cells restrict memory CD8+T cell responses. J Exp Med 2002; 196: 1585-1592.
41. Dai Z, Li Q, Wang Y, et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310-317.
42. Murakami M, Sakamoto A, Bender J, Kappler J, Marrack P. CD25+CD4+T cells contribute to the control of memory CD8+T cells. Proc Natl Acad Sci USA 2002; 99: 8832-8837.
43. Ji J, Masterson J, Sun J, Soong L. CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 2005; 174: 7147-7153.